ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,741 | -2.0% | 27,709 | 0.0% | 0.11% | -9.0% |
| Q2 2023 | $553,072 | +2.0% | 27,709 | 0.0% | 0.12% | -40.5% |
| Q4 2022 | $542,265 | +26.1% | 27,709 | 0.0% | 0.20% | +95.2% |
| Q3 2022 | $430,000 | +7.5% | 27,709 | 0.0% | 0.10% | +19.3% |
| Q2 2022 | $400,000 | -8.9% | 27,709 | 0.0% | 0.09% | +2.3% |
| Q1 2022 | $439,000 | -32.0% | 27,709 | 0.0% | 0.09% | -23.2% |
| Q4 2021 | $646,000 | -21.6% | 27,709 | 0.0% | 0.11% | -25.3% |
| Q3 2021 | $824,000 | -34.3% | 27,709 | 0.0% | 0.15% | -38.5% |
| Q2 2021 | $1,255,000 | +7.9% | 27,709 | 0.0% | 0.24% | -0.8% |
| Q1 2021 | $1,163,000 | -24.4% | 27,709 | 0.0% | 0.25% | -29.7% |
| Q4 2020 | $1,538,000 | +99.2% | 27,709 | 0.0% | 0.35% | +66.7% |
| Q3 2020 | $772,000 | – | 27,709 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |